Literature DB >> 10978165

Posttranslationally processed forms of the human chemokine HCC-1.

R Richter1, P Schulz-Knappe, H John, W G Forssmann.   

Abstract

HCC-1 is the only CC-chemokine known so far which circulates in nanomolar concentrations in human plasma. Its physiological function is not well defined. Posttranslational processing of HCC-1 was shown to modulate its biological properties. In this study several different processed forms of HCC-1 were isolated. Western blot analysis of human plasma extracts revealed a HCC-1 immunoreactive double band at 8-10 kDa indicating the presence of two distinct HCC-1 peptides. These peptides were isolated from a peptide library of human blood filtrate and represent predominantly HCC-1 (1-74) and glycosylated HCC-1 (1-74). Glycosylated HCC-1 exhibits a molecular mass of 9621 Da due to O-glycosylation at position 7 (Ser-7) with two N-acetylneuraminic acids and the disaccharide N-acetylgalactosamine galactose. Furthermore N-terminally truncated HCC-1 (3-74) and HCC-1 (4-74) were identified in the peptide library. In hemofiltrate approximately 3% of total HCC-1 represents HCC-1 (3-74) and approximately 1% represents HCC-1 (4-74) whereas the major products are nonglycosylated HCC-1 (1-74) and glycosylated HCC-1 (1-74). Our data imply that HCC-1 (1-74), HCC-1 (3-74), HCC-1 (4-74) and glycosylated HCC-1 (1-74) circulate in human blood. The N-terminal processing and modification of HCC-1 might be of importance in displaying its full biological activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978165     DOI: 10.1021/bi992488q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages.

Authors:  Jan Münch; Ludger Ständker; Stefan Pöhlmann; Frédéric Baribaud; Armin Papkalla; Olaf Rosorius; Roland Stauber; Gabriele Sass; Nikolaus Heveker; Knut Adermann; Sylvia Escher; Enno Klüver; Robert W Doms; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 2.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

3.  Targeting the glycoproteome.

Authors:  Jonas Nilsson; Adnan Halim; Ammi Grahn; Göran Larson
Journal:  Glycoconj J       Date:  2012-08-11       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.